172@29@16@13!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=1&is_responsive=1&sec=&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
App
Moneycontrol App Android App iOS App iPad App Android Tab Blackberry Windows App Windows Tab
Subscription
Specials
Stocks
Feedback
Log In
Sign Up
Moneycontrol
Close Ad
SENSEX NIFTY
you are here:
MARKETS DATA

Claris Lifesciences Ltd.

BSE: 533288 | NSE: | Series: NA | ISIN: INE562G01018 | SECTOR: Pharmaceuticals

| BSE 396.55 0.00 (0.00%) | |

BSE Live

Mar 14, 16:00
396.55 0.00 (0.00%)
Volume
No Data Available
76,598

  • Prev. Close

    396.55

  • Open Price

    395.10

395.00

Today’s L/H

396.90
308.00

52 Wk L/H

425.70
317.45

L/U Price Band

476.15

  • Bid Price (Qty.)

    395.00 (1000)

  • Offer Price (Qty.)

    396.55 (187)

  •  VWAP

    396.34
     Beta
    0.16

  • Market Depth (14 Mar 2018)

    BUYSELL
    QTY PRICE PRICE QTY
    25 396.55 396.65 40
    588 396.50 396.70 200
    188 396.00 396.80 615
    200 395.75 396.90 504
    3 395.30 396.95 233
    541 Total Total 5018
     Market Depth
    BUY 541.00
    SELL 5018.00
    10%
    90%
Claris Lifesciences is not traded on BSE in the last 30 days

NSE Live

Dec 27, 11:22
NT* 0.00 (0.00%)
Volume
No Data Available
0

  • Prev. Close

    -

  • Open Price

    -

-

Today’s L/H

-
-

52 Wk L/H

-

L/U Price Band

  • Bid Price (Qty.)

    - (0)

  • Offer Price (Qty.)

    - (0)

  •  VWAP

    -
     Beta
    0.00
  • DELIVERY AVERAGES
    3-Day
    0%
    5-Day
    0%
    8-Day
    0%
    Deliverables
    0%
  • SMA
Claris Lifesciences is not listed on NSE

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Very Bullish
Moving Averages Bullish
Technical Indicators Bullish
Moving Averages Crossovers Bullish
See Detail
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 397.30 398.05 399.20 396.15 395.40 394.25 393.50
Fibonacci 396.88 397.32 398.05 396.15 395.42 394.98 394.25
Camarilla 396.72 396.90 397.07 396.15 396.38 396.20 396.03

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days BSE
5 396.08
10 394.66
20 392.43
50 378.38
100 364.15
200 361.70
Get Historical Prices
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

Type R1 R2 R3 PP S1 S2 S3
Classic 398.00 399.45 401.90 395.55 394.10 391.65 390.20
Fibonacci 397.04 397.96 399.45 395.55 394.06 393.14 391.65
Camarilla 396.91 397.26 397.62 395.55 396.19 395.84 395.48

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 398.95 401.35 405.50 394.80 392.40 388.25 385.85
Fibonacci 397.30 398.85 401.35 394.80 392.30 390.75 388.25
Camarilla 397.15 397.75 398.35 394.80 395.95 395.35 394.75

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      2,163.88
    • P/E
      1.58
    • Book Value (Rs)
      135.66
    • Dividend (%)
      20.00
    • Market Lot
      1
    • Industry P/E
      28.87
    • EPS (TTM)
      250.66
    • P/C
      1.58
    • Price/Book
      2.92
    • Dividend Yield.(%)
      0.50
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      94.22
      5-Day
      95.24
      8-Day
      93.36
      98.14

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      2,163.88
    • P/E
      1.37
    • Book Value (Rs)
      186.91
    • Dividend (%)
      20.00
    • Market Lot
      1
    • Industry P/E
      28.87
    • EPS (TTM)
      289.37
    • P/C
      1.37
    • Price/Book
      2.12
    • Dividend Yield.(%)
      0.50
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      94.22
      5-Day
      95.24
      8-Day
      93.36
      98.14

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

No Data For Community Sentiments.

What's your call on today?

Read 0 investor views

BUY SELL HOLD
POST

Action in Claris Lifesciences Ltd.

News & Videos

USFDA issues warning letter to Claris Injectables

USFDA issues warning letter to Claris Injectables

Business | Earnings | Management Interviews
View More

News across the web

Data not available

Announcements

View More

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded
NSE - No shares traded

Financials

(Rs. Cr)
(Rs. Cr)
Profit & Loss Nine Months Results Half Yearly Results Quarterly Results
(Rs. Cr)
(Rs. Cr)
Quarterly | Half Yearly | Nine Months | Annual
Quarterly DEC 2017 SEP 2017 JUN 2017 MAR 2017 DEC 2016
Sales
0 2 1 3 7
Other Income
57 43 10 -2 9
Total Income
57 46 11 0 17
Total Expenditure
15 13 16 12 24
EBIT
-318 1,705 -1 -8 3
Interest
0 0 0 1 0
Tax
0 11 -2 -3 -5
Net Profit
-320 1,693 0 -5 8
Profit & Loss Nine Months Results Half Yearly Results Quarterly Results

Historical Prices

On
 Current Price %Gain / Loss
No Record Found
On
 Current Price %Gain / Loss
No Record Found
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11930.40 33.90 0.28
SENSEX 40685.50 127.01 0.31
NIFTY BANK 24478.30 -5.85 -0.02
NIFTY IT 21523.60 110.10 0.51
S&P BSE Smallcap 15134.59 106.51 0.71
View More
Index Price Change %Chg
Nasdaq (Oct 24) 11,548.28 42.27 0.37
DAX (Oct 23) 12,645.75 102.69 0.82
FTSE (Oct 23) 5,860.28 74.63 1.29
CAC (Oct 23) 4,909.64 58.26 1.20
SGX Nifty (Oct 24) 11,970.00 35.00 0.29
View More

CORPORATE ACTION

Date Agenda
No Board Meetings Information is available for Claris Lifesciences
View More
Type Dividend% Ex-Dividend date
Final 20.00 Sep 11, 2017
Final 20.00 Jul 21, 2016
Interim 90.00 Jan 20, 2014
Final 20.00 Apr 04, 2013
Final 20.00 Apr 20, 2012
View More
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Claris Lifesciences
View More
Old FV New FV Ex-Split
No Splits Information is available for Claris Lifesciences
View More
Ratio Premium Ex-Bonus
No Rights Information is available for Claris Lifesciences
View More
Date Agenda
Jan 23, 2017 -
Sep 19, 2017 -
Feb 17, 2017 -
Jul 29, 2016 Rs.2.0000 per share(20%)Final Dividend
Mar 25, 2016 -
View More

Dividend Summary

For the year ending March 2017 Claris Lifesciences has declared an equity dividend of 20.00% amounting to Rs 2 per share. At the current share price of Rs NT* this results in a dividend yield of 0%.

Claris Lifesciences had last declared a dividend of 20.00% for the year ending March 2017.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone December 2017 September 2017 June 2017 March 2017
Promoters 50.13 50.13 50.13 50.13
Pledged 32.91 32.91 32.91 32.91
FII/FPI 26.02 25.62 26.22 26.48
Total DII 12.48 11.34 11.07 10.29
Fin.Insts 0 0 0 0
Insurance Co 0 0 0 0
MF 1.93 1.93 1.86 1.86
Others DIIs 10.55 9.41 9.21 8.43
Others 11.37 12.9 12.58 13.1
Total 100 99.99 100 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
ABB Power Produ 981.80 1.15 1100.00 749.70 4161.03 3,230.74 165.39
Hemisphere 95.70 -4.97 106.00 10.00 2727.45 -- --
WARDWIZARD INNO 379.00 3.72 383.65 72.00 831.65 0.10 -0.91
SEACOAST SS 90.35 -1.95 92.15 18.75 202.79 0.52 0.05
Nivaka Fashions 8.70 0.00 12.84 7.65 89.34 21.55 -0.84

COMPANY OVERVIEW

Claris Lifesciences Ltd. is one of the largest Indian sterile injectables pharmaceutical companies.The companys products, ranges across various therapeutic segments, including anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral nutrition, parenteral nutrition and oncology. They offer injectables in various delivery systems, such as glass and plastic bottles, vials, ampules, pre-filled syringes and non-PVC and PVC bags. The companys product range includes Anesthesia,Bupivacaine Injection,Ketamine Injection IP,Propofol Intravenous anesthesia,Midazolam Injection BP,Lidocaine Injection IP,Thiopentone Sodium for Injection IP and Propofol Spiva.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Surrinder Lal Kapur

      Chairman & Ind.Dire (Non-Exe)

    • Arjun Handa

      Vice Chairman & Mng.Director

    • Chandrasingh S Purohit

      WholeTime Director & CFO

    • Shyamsunder Sharma

      Whole Time Director

    • T V Ananthanarayanan

      Non Exe. & Ind. Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Claris Lifesciences Ltd.

Claris Life is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 533288.

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Claris Lifesciences Stock Price | Claris Life Stock Quote | Claris Life Results | Claris Life News | View All Related Searches
Sections
Desktop Version »
Follow us on
Facebook Twitter Instagram Teglegram
Available On
Download from Google Play Download from App Stoer Download from Windows Phone
Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Feedback
Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.